Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD

C. Castro Riera (Madrid, Spain), J. De Miguel Diez (Madrid, Spain), Z. Ji (Madrid, Spain), A. López De Andrés (Alcorcón, Spain), V. Hernández Barrera (Alcorcón, Spain), I. Domínguez Zabaleta (Madrid, Spain), V. Parra León (Madrid, Spain), L. Puente Maestu (Madrid, Spain), R. Jiménez García (Madrid, Spain)

Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Session: Lower respiratory tract infections in clinical practice
Session type: E-poster session
Number: 3101
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Castro Riera (Madrid, Spain), J. De Miguel Diez (Madrid, Spain), Z. Ji (Madrid, Spain), A. López De Andrés (Alcorcón, Spain), V. Hernández Barrera (Alcorcón, Spain), I. Domínguez Zabaleta (Madrid, Spain), V. Parra León (Madrid, Spain), L. Puente Maestu (Madrid, Spain), R. Jiménez García (Madrid, Spain). Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD. 3101

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009

Community-acquired pneumonia (CAP) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003

Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)?
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003

Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006



Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients
Source: Eur Respir J 2012; 39: 855-861
Year: 2012



Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbations
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009



Genomic variability of haemophilus in patients with COPD
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006


Mycoplasma pneumoniae infection and acute exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006

How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients?
Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients
Year: 2015



Calorie-intake in patients hospitalized for an acute COPD exacerbation
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007



Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Prevelance of anemia in patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006


Infection as a comorbidity of COPD
Source: Eur Respir J 2010; 35: 1209-1215
Year: 2010



Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


A study of exacerbations by Gram-negative organisms in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007

Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


7 Years survival of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 211s
Year: 2001